These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19174530)

  • 1. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
    Schreiner F; Tozakidou M; Maslak R; Holtkamp U; Peter M; Gohlke B; Woelfle J
    Eur J Endocrinol; 2009 Apr; 160(4):667-73. PubMed ID: 19174530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
    Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J
    Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
    Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
    Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY; Yee JK; Hicks RA; Mao CS; Lee WN
    J Perinatol; 2017 Mar; 37(3):283-287. PubMed ID: 27929529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
    Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
    Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.
    Lacey JM; Minutti CZ; Magera MJ; Tauscher AL; Casetta B; McCann M; Lymp J; Hahn SH; Rinaldo P; Matern D
    Clin Chem; 2004 Mar; 50(3):621-5. PubMed ID: 14656905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-tandem mass spectrometry analysis of 17-hydroxyprogesterone in dried blood spots revealed matrix effect on immunoassay.
    Han L; Tavakoli NP; Morrissey M; Spink DC; Cao ZT
    Anal Bioanal Chem; 2019 Jan; 411(2):395-402. PubMed ID: 30456606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
    Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
    Koetz KR; van Rossum EF; Ventz M; Diederich S; Quinkler M
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):831-7. PubMed ID: 23134110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency.
    Luczay A; Török D; Ferenczi A; Majnik J; Sólyom J; Fekete G
    Eur J Endocrinol; 2006 Jun; 154(6):859-64. PubMed ID: 16728546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
    Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
    J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a candidate reference measurement procedure for detecting 17α-hydroxyprogesterone in dried blood spots using isotope dilution liquid chromatography tandem mass spectrometry.
    He Z; Dai H; Shen J; Huang Y; Liu J; Yan R; Zhang F; Yan S
    Anal Bioanal Chem; 2024 Aug; 416(20):4635-4645. PubMed ID: 38949681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
    Mitchell ML; Hermos RJ
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):757-60. PubMed ID: 9713565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of a steroid profile in heel prick blood using LC-MS/MS.
    Boelen A; Ruiter AF; Claahsen-van der Grinten HL; Endert E; Ackermans MT
    Bioanalysis; 2016; 8(5):375-84. PubMed ID: 26891684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F; Török D; Kovács J; Möslinger D; Baumgartner-Parzer SM; Sólyom J; Pribilincová Z; Battelino T; Lebl J; Frisch H; Waldhauser F;
    Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.